Friday, September 20, 2013 7:36:35 PM
“For lack of a better term, DAVEI ‘tricks’ the virus into ‘thinking’ it is about to infect a healthy cell, when, in fact, there is nothing there for it to infect,” Abrams said. “Instead, it releases its genetic payload harmlessly and dies.”
The DAVEI molecule is comprised of two pieces: Membrane Proximal External Region (MPER) and cyanovarin (CVN) which allows it to attach to both the viral membrane and the protein spike of the virus. This allows DAVEI to make the virus behave as if it's attached to a healthy cell.
If I understand this mechanism correctly, the pop of the virus structure is normal once inside the cell but what is not normal is that when attached to DAVEI the virus is tricked (transfers control to EXIT) to pop open outside a cell where it releases its genetic material and is rendered harmless.
In the case of Nanoviricides, Inc., the virus structure attaches to the nanoviricide, the nanoviricide opens up and the lethal "hidden tails" cover the virus particle lipid coat and destroys it rendering it harmless.
DAVEI may be competition years down the road but once Nanoviricides, Inc. reaches the market and proves to be effective the other may not get too far. Too early to say with certainty though. We will continue with the "transformational technology" of Nanoviricides, Inc., keep an eye on the competition and time will tell if their "wheel" is good enough or better than Nanoviricides, Inc. "wheel". You are vested in the success of Nanoviricides, Inc. like many of us are here, and I believe you have agreed that time is on the side of Nanoviricides, Inc., as the Rolling Stones say,...have a great weekend!
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM